Answers are grounded in this paper and cite their sources.
In vitro study reveals direct binding and inhibition of complement component C1 by bacterial lipopolysaccharides and lipid A, indicating selective classical pathway interactions.
Lipopolysaccharides of Gram-negative bacteria (LPS) known to activate the complement system via the alternate pathway bypassing C1̄, C4, and C2 had a direct effect on purified C1̄, but no effect on purified C4 and C2. These studies were performed with different preparations of LPS and of Lipid-A isolated from smooth (S-) and rought (R-) forms of Escherichia coli and Salmonella strains. It was shown that the effect of LPS on C1̄ depends upon the concentration and type of LPS applied: 0.77 µg of LPS from E. coli 0 75, 2.5 µg of LPS from S. minnesota R 595, 24 µg of Lipid-A and 55 µg of Lipid-A/BSA were necessary to get 50% inhibition of free C1̄. In contrast, 100 µg of LPS from E. coli 0 111, from S minnesota S-form, or from S. minnesota R 345 showed no significant inhibition. Binding of C1̄ to EA or EAC4 markedly reduced the effect of LPS and of Lipid-A on C1̄. The inhibition of C1̄ was shown to be the result of a direct interaction of LPS and of Lipid-A with the C1 subunit C1q: LPS precipitated C1q. LPS and Lipid-A had no effect on the C1 esterase activity against C2.
No takes yet. Share an insight, caveat, or question.
Loos et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: